In the rapidly advancing realm of modern medicine, gene-modified cell therapies are set to redefine oncology. PMWC, 2024 Silicon Valley Conference on January 24-26 is a beacon for those eager to delve into this transformative shift and harness the potential of oncology-focused cell therapies.
As Ira Mellman (Genentech & PMWC 2024 Speaker) highlights “Creating, preparing, and engineering cells for patient reintegration involves synthetic biology. Understanding this process is key to its success.”
The horizon is illuminated with groundbreaking technologies, including the integration of AI and Machine Learning for intricate patient profiling, and the development of efficient cell expansion techniques. This wave of innovation heralds a new era of tailored and precise treatments for cancer patients.
However, the journey is not without its challenges. Mellman emphasizes, “Balancing safety concerns with the need for rapid therapy modifications is crucial. Flexibility in regulation can support innovation.”
This conference serves as a nexus for professionals committed to addressing these challenges and propelling innovation in cell-based therapies. George Coukos (Ludwig Cancer Research & PMWC 2024 Honoree in Tumor Immunology) will illuminate the path forward, emphasizing, “The imperative is to employ state-of-the-art technologies like AI and ML to lead the way in developing personalized cell therapies. These tools will not only help address challenges of individual patient profiles and tumor characteristics but also address issues related to production efficiency and scalability.”
Our sessions are thoughtfully curated to offer a deep dive into pivotal aspects of cell therapies. This ranges from the discovery of innovative cell therapy targets, under the guidance of Sharon Benzeno (Adaptive Biotechnologies & PMWC Track Chair), to delving into cell therapy applications in clinical trials, the evolution of supply chains, cost considerations, and the pivotal role of AI/Machine Learning. Each segment promises to equip attendees with profound insights into the latest advancements in cell therapy.
We are thrilled to extend an invitation for you to be part of the 23rd PMWC conference from January 24-26 (Full Speaker Lineup). Our distinguished panelists, leading the charge in these breakthroughs, are poised to spark transformative discussions and insights.
Highlighted sessions and speakers include:
Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
Stanley Riddell, Fred Hutchinson
Allison Betof Warner, Stanford
Lawrence Fong, UCSF
Scientific Advancements in Individualized Cell Therapeutics for Oncology (PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
Ira Mellman, Genentech
George Coukos, Ludwig Institute for Cancer Research
Bobert Meehan, Moderna
Dirk Nagorsen, Affini-T Therapeutics
Supply Chain 2.0: Getting Cell Therapies to Patients (PANEL)
Chair: John Knighton, Janssen Pharmaceuticals
Amanda Pace, Sonoma Bio
Wendy Tzeng, Sana Biotechnology
AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
Brian Weitzner, Outpace Bio
Richard Bonneau, Prescient Design
Join us in this enlightening journey into the future of oncology-focused cell therapies.
Register Today.
Best regards,
Tal Behar
President & Co-founder, PMWC
PMWC 2024 Silicon Valley – January 24-26, 2024
The Precision Medicine World Conference (PMWC)
